Therapeutic rounds: neuroleptic malignant syndrome.
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001971:Bromocriptine / Q000627:therapeutic use; D002389:Catatonia / Q000175:diagnosis; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis*; D010302:Parkinson Disease, Secondary / Q000175:diagnosis* / Q000188:drug therapy
D014150:Antipsychotic Agents; D001971:Bromocriptine